This session on neuromuscular disorders is a focused gathering that brings together experts, researchers, and healthcare professionals to discuss and share insights into various aspects of neuromuscular disorders. These disorders involve the malfunctioning of the nerves that control voluntary muscles, leading to conditions such as muscular dystrophy, myasthenia gravis, spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
Key components of this session include Research Advances, Diagnostic Techniques, Therapeutic Approaches, Patient Perspectives, Interdisciplinary Collaboration, Emerging Technologies, Policy and Advocacy.
In summary, a special session on neuromuscular disorders aims to create a platform for sharing knowledge, fostering collaboration, and advancing the understanding and treatment of these complex conditions.
University of Missouri-Columbia
USA
Vall d’Hebron Hospital
Spain
Co-Founder of SMATHERIA
Germany
University of Pittsburgh School of Medicine, USA
University of Ottawa
Canada
NINDS/NIH
USAs
Stony Brook University
USA
USC Mann School of Pharmacy & Pharmaceutical Sciences, USA